More Unnecessary Imaginary Worlds - Part 1: The Institute for Clinical and Economic Review’s Evidence Report on Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis

More Unnecessary Imaginary Worlds - Part 1: The Institute for Clinical and Economic Review’s Evidence Report on Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis

Previous commentaries in the Formulary Evaluation section of INNOVATIONS in Pharmacy have pointed to the lack of credibility in modeled claims for cost-effectiveness and associated recommendations for pricing by the Institute for Clinical and Economic Review (ICER). The principal objection to ICER...

Full description

Bibliographic Details
Main Author: Paul Langley
Format: Article
Language:English
Published: University of Minnesota Libraries Publishing 2020-01-01
Series:INNOVATIONS in Pharmacy
Subjects:
Rheumatoid Arthritis (RA), Janus Kinase (JAK) Inhibitors, ICER pseudoscience, unnecessary distraction, patient voice, Rasch Measurement Theory (RMT)
Online Access:https://pubs.lib.umn.edu/index.php/innovations/article/view/2402

Similar Items

Similar Items